Actively Recruiting
Assessment of Early Brain Injury and Neurological Outcome in Adults After Cardiac Arrest
Led by Nantes University Hospital · Updated on 2025-02-26
608
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a study to improve the early prediction of brain damage in patients who have been resuscitated after cardiac arrest and admitted to intensive care. Brain injuries cause many deaths in these patients, so identifying who has neurological lesions is important for targeting neuroprotective treatments. The study aims to develop a simple and quick tool to assess brain injury severity early on, helping guide care decisions without exposing patients without lesions to unnecessary treatments. This research is an observational trial where investigators will measure specific biomarkers, UCHL-1 and GFAP, when patients arrive in intensive care. These biomarkers are proteins linked to brain injury. The study will also track neurological outcomes 90 days after enrollment using the modified Rankin scale. The goal is to see how well early biomarker levels predict later brain function. Participants will be adults admitted to intensive care after out-of-hospital cardiac arrest who are comatose on arrival. Researchers will collect biomarker samples at admission and again 4 hours after recovery of effective cardiac activity. They will monitor neurological status over 90 days to evaluate outcomes. The study seeks to provide reliable early information to improve post-cardiac arrest care while avoiding unnecessary treatments for those without brain injury.
CONDITIONS
Brief Title
Early and Objective Assessment of Neurological Prognosis in Cardiac Arrest Patients
Research Team
J
Jean-Baptiste LASCARROU
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here